Global Antibiotic Resistance Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 171
Status: Published
Report Code: ARI101027
Antibiotic resistance (ABR) happens because of additional and uncontrolled use of antibiotics. Most antibiotics are sold as over-the-counter drugs, with many people using them without receiving prescriptions from a physician. Also, most physicians, especially in emerging countries, prescribe antibiotics for viral diseases without diagnosing the disease properly. All these factors eventually lead to the growth of antibiotic resistance.
Antibiotics are easily available through drugstores, and growing preference for online pharmacies is also increasing the convenience of antibiotic resistance goods from key players. Addressing antibiotic resistance is difficult because patients, physicians, hospitals, pharmaceutical companies, and agricultural users have inadequate incentives to act in ways that would conserve antibiotic effectiveness.
These challenges suggest the simultaneous deployment of multiple strategies: vaccination to prevent infection and reduce request for antibiotics, aggressive hospital infection control, judicious prescribing and cycling of antibiotics, treatment with narrow-spectrum antibiotics, development of new antibiotics, AMR communication strategies, and coordinated federal policies that steward this resource. The development in antibiotic medications shipped in non-industrial nations is boosting the antibiotic resistance market. Increasing level of bacterial contamination has prompted dispatch of different antibiotic medications, accordingly driving the development of the market all around the world.
The interest for antibiotic resistance is increasing because of nonattendance of cognizance or the maltreatment or abuse of antibiotics. The development of the antibiotic resistance industry can be eased back by the rigid authoritative instrument to endorse antibiotic resistance treatments. Moreover, an absence of financial backer worry in the innovative work of resistance treatments to antibiotics will likewise thwart the market for antibiotic resistance.
The classification of antibiotics is based on chemical structures, activity spectrum and action method. The capacity to withstand the infection is known as resistance to antibiotics. Worldwide, this is likely to be a key issue, leading to full-fledged appearance of the global antibiotic resistance market.
Developments in generic drugs and the increasing susceptible aging population are also contributing to the overall growth of this market. The antibiotics market is expected to exhibit significant growth during the forecast period, due to rise in request for new generation antibiotics that can resolve the issue of antimicrobial resistance.
Additionally, growth of innovative approaches for new antibiotics for treating bacterial infections and increase in number of clinical trials supplement the growth of the antibiotics market. Increasing disease burden is compelling government and non-government bodies to invest in R&D initiatives and boost the development of novel antibiotics and helpful regulatory policies to expedite the approval process and research funding.
The associations for the development of antibiotics are expected to lead to the development of a high number of antibiotic drugs in the foreseeable future. Pharmaceutical companies are cooperating for the development of new therapies to reduce the cost burden of the drug development process.
Moreover, the increasing number of public-private collaborations, wherein funding and innovative R&D approaches are providing by public agencies to firms developing antibiotics, is expected to boost the product pipeline. The rising threat of drug resistance and a weak pipeline of new molecules are important to the development of combinational formulations.
Antibiotic medicines refer to medicines used to treat infections by killing bacteria. These are among the most prescribed courses worldwide in fighting bacterial infections, mainly in outpatient antimicrobial resistance would elevate the rate of poverty and impact low-income countries related to the rest of the world settings. The use of antibiotics has saved millions of lives, but its pervasive use to treat any infection, whether serious, minor, or even viral has led to the rise in antibiotic resistance.
Table of Contents
Chapter 1 Executive Summary 16
1.1 Global Antibiotic Resistance Market: Executive Summary 16
1.1.1 Global Antibiotic Resistance Market Revenue, 2015-2028(USD Million) 18
Chapter 2 Research Methodology 19
2.1 Methodology/Research Approach 19
2.1.1 Research Programs/Design 19
2.1.2 Market Size Estimation 20
2.2 Data Source 20
2.2.1 Secondary Sources 20
2.2.1.1 Preliminary data mining 21
2.2.2 Primary Sources 21
2.2.2.1 Data Collection Matrix 23
2.2.3 Statistical model 23
2.2.4 Data Triangulation 24
2.2.5 Report Objectives 24
Chapter 3 Market Outlook 25
3.1 Key Trends 25
3.1.1 Increasing in clinical developments of antibiotic resistance 25
3.2 Market Drivers 26
3.2.1 Rise in incidence of chronic and infectious disease 26
3.3 Market Restraints 28
3.3.1 High medical costs 28
3.4 Market Opportunities 29
3.4.1 The discovery of advanced prospect molecules and introduction of novel combination therapies to treat antibiotic-resistant microbial infections 29
3.5 Market Challenges 30
3.5.1 Time required for the regulatory approval 30
3.6 Impact Analysis of Driver, Restraint, Opportunity and Challenge 31
3.7 Porter’s Five Forces Analysis 32
3.7.1 Bargaining Power of Suppliers: Moderate 32
3.7.2 Bargaining Power of Buyers: Low to Moderate 33
3.7.3 Threat of New Entrants: Moderate 34
3.7.4 Threat of Substitutes: Moderate 35
3.7.5 Competitive Rivalry: Moderate 36
Chapter 4 Impact of COVID-19 on Antibiotic Resistance Market 37
Chapter 5 Global Antibiotic Resistance Market Overview, By Drug Class 2015, 2021 and 2028 (%) 38
5.1 Global Antibiotic Resistance Market Revenue Share, By Drug Class, 2015, 2021 and 2028 (%) 38
5.2 Global Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 39
5.3 Β-Lactam Antibiotics 40
5.3.1 Introduction 40
5.3.2 Global Antibiotic Resistance Market Revenue, By Β-Lactam Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million) 41
5.4 Cephalosporin 42
5.4.1 Introduction 42
5.4.2 Global Antibiotic Resistance Market Revenue, By Cephalosporin, By Drug Class, By Region, 2015 - 2028 (USD Million) 43
5.5 Quinolones Antibiotics 44
5.5.1 Introduction 44
5.5.2 Global Antibiotic Resistance Market Revenue, By Quinolones Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million) 45
5.6 Macrolide Antibiotics 46
5.6.1 Introduction 46
5.6.2 Global Antibiotic Resistance Market Revenue, By Macrolide Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million) 47
5.7 Tetracycline 48
5.7.1 Introduction 48
5.7.2 Global Antibiotic Resistance Market Revenue, By German, By Drug Class, By Region, 2015 - 2028 (USD Million) 49
5.8 Other 50
5.8.1 Introduction 50
5.8.2 Global Antibiotic Resistance Market Revenue, By Other, By Drug Class, By Region, 2015 - 2028 (USD Million) 51
Chapter 6 Global Antibiotic Resistance Market Overview, By Disease 2015, 2021 and 2028 (%) 52
6.1 Global Antibiotic Resistance Market Revenue Share, By Disease, 2015, 2021 and 2028 (%) 52
6.2 Global Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 53
6.3 CABP 54
6.3.1 Introduction 54
6.3.2 Global Antibiotic Resistance Market Revenue, By CABP, By Disease, By Region, 2015 - 2028 (USD Million) 55
6.4 cUTI 56
6.4.1 Introduction 56
6.4.2 Global Antibiotic Resistance Market Revenue, By cUTI, By Disease, By Region, 2015 - 2028 (USD Million) 57
6.5 cIAI 58
6.5.1 Introduction 58
6.5.2 Global Antibiotic Resistance Market Revenue, By cIAI, By Drug Class, By Region, 2015 - 2028 (USD Million) 59
6.6 BSI 60
6.6.1 Introduction 60
6.6.2 Global Antibiotic Resistance Market Revenue, By BSI, By Drug Class, By Region, 2015 - 2028 (USD Million) 61
6.7 Others 62
6.7.1 Introduction 62
6.7.2 Global Antibiotic Resistance Market Revenue, By Others, By Drug Class, By Region, 2015 - 2028 (USD Million) 63
Chapter 7 Global Antibiotic Resistance Market Overview, By Distribution Channel 2015, 2021 and 2028 (%) 64
7.1 Global Antibiotic Resistance Market Revenue Share, By Distribution Channel, 2015, 2021 and 2028 (%) 64
7.2 Global Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 65
7.3 Hospital Pharmacy 66
7.3.1 Introduction 66
7.3.2 Global Antibiotic Resistance Market Revenue, By Hospital Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million) 67
7.4 Retail Pharmacy 68
7.4.1 Introduction 68
7.4.2 Global Antibiotic Resistance Market Revenue, By Retail Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million) 69
7.5 Online Pharmacy 70
7.5.1 Introduction 70
7.5.2 Global Antibiotic Resistance Market Revenue, By Online Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million) 71
Chapter 8 Global Antibiotic Resistance Market Overview, By Geography, 2015, 2021 and 2028 (%) 72
8.1 Global Antibiotic Resistance Market Revenue Share, By Geographic Regions, 2015, 2021 and 2028 (%) 72
8.2 Global Antibiotic Resistance Market Revenue, By Geographic Regions, 2015 - 2028 (USD Million) 73
Chapter 9 North America Antibiotic Resistance Market Overview, By Countries 74
9.1 North America Antibiotic Resistance Market Overview, 2015 - 2028 74
9.1.1 Introduction 74
9.1.2 North America Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 75
9.1.3 North America Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 76
9.1.4 North America Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 77
9.1.5 North America Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028 78
9.1.6 North America Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million) 79
9.1.6.1 U.S. Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 80
9.1.6.2 U.S. Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 81
9.1.6.3 U.S. Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 81
9.1.6.4 Canada Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 82
9.1.6.5 Canada Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 83
9.1.6.6 Canada Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 83
9.1.6.7 Mexico Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 84
9.1.6.8 Mexico Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 85
9.1.6.9 Mexico Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 85
Chapter 10 Europe Antibiotic Resistance Market Overview, By Countries 86
10.1 Europe Antibiotic Resistance Market Overview, 2015 - 2028 86
10.1.1 Introduction 86
10.1.2 Europe Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 87
10.1.3 Europe Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 88
10.1.4 Europe Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 88
10.1.5 Europe Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028 89
10.1.6 Europe Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million) 90
10.1.6.1 Germany Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 91
10.1.6.2 Germany Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 92
10.1.6.3 Germany Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 92
10.1.6.4 UK Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 93
10.1.6.5 UK Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 94
10.1.6.6 UK Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 94
10.1.6.7 France Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 95
10.1.6.8 France Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 96
10.1.6.9 France Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 96
10.1.6.10 Italy Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 97
10.1.6.11 Italy Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 98
10.1.6.12 Italy Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 98
10.1.6.13 Spain Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 99
10.1.6.14 Spain Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 100
10.1.6.15 Spain Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 100
10.1.6.16 Rest of Europe Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 101
10.1.6.17 Rest of Europe Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 102
10.1.6.18 Rest of Europe Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 102
Chapter 11 Asia Pacific Antibiotic Resistance Market Overview, By Countries 103
11.1 Asia Pacific Antibiotic Resistance Market Overview, 2015 - 2028 103
11.1.1 Introduction 103
11.1.2 Asia Pacific Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 105
11.1.3 Asia Pacific Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 106
11.1.4 Asia Pacific Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 106
11.1.5 Asia Pacific Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028 107
11.1.6 Asia Pacific Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million) 108
11.1.6.1 China Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 109
11.1.6.2 China Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 110
11.1.6.3 China Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 110
11.1.6.4 India Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 111
11.1.6.5 India Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 112
11.1.6.6 India Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 112
11.1.6.7 Japan Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 113
11.1.6.8 Japan Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 114
11.1.6.9 Japan Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 114
11.1.6.10 South Korea Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 115
11.1.6.11 South Korea Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 116
11.1.6.12 South Korea Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 116
11.1.6.13 Rest of Asia-Pacific Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 117
11.1.6.14 Rest of Asia-Pacific Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 118
11.1.6.15 Rest of Asia-Pacific Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 118
Chapter 12 Middle East and Africa Antibiotic Resistance Market Overview, By Countries 119
12.1 Middle East and Africa Antibiotic Resistance Market Overview, 2015 - 2028 119
12.1.1 Introduction 119
12.1.2 Middle East and Africa Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 120
12.1.3 Middle East and Africa Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 121
12.1.4 Middle East and Africa Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 121
12.1.5 Middle East and Africa Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028 122
12.1.6 Middle East and Africa Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million) 123
12.1.6.1 GCC Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 124
12.1.6.2 GCC Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 125
12.1.6.3 GCC Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 125
12.1.6.4 South Africa Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 126
12.1.6.5 South Africa Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 127
12.1.6.6 South Africa Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 127
12.1.6.7 ROMEA Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 128
12.1.6.8 ROMEA Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 129
12.1.6.9 ROMEA Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 129
Chapter 13 South America Antibiotic Resistance Market Overview, By Countries 130
13.1 South America Antibiotic Resistance Market Overview, 2015 - 2028 130
13.1.1 Introduction 130
13.1.2 South America Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 131
13.1.3 South America Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 132
13.1.4 South America Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 132
13.1.5 South America Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028 133
13.1.6 South America Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million) 134
13.1.6.1 Brazil Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 135
13.1.6.2 Brazil Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 136
13.1.6.3 Brazil Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 136
13.1.6.4 Argentina Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 137
13.1.6.5 Argentina Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 138
13.1.6.6 Argentina Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 138
13.1.6.7 Rest of South America Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 139
13.1.6.8 Rest of South America Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 140
13.1.6.9 Rest of South America Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 140
Chapter 14 Competitive Landscape 141
14.1 Competitive Environment, 2021 141
14.2 Strategic Framework 142
14.2.1 Recent Initiatives 142
Chapter 15 Key Vendor Analysis 143
15.1 Pfizer Inc 143
15.1.1 Company Basic information 143
15.1.2 Company Profile: 143
15.1.3 Financial Overview (USD Billion): 144
15.1.4 Product Benchmarking 144
15.1.5 Recent Developments 144
15.1.6 SWOT Analysis 145
15.2 GlaxoSmithKline plc 146
15.2.1 Company Basic information 146
15.2.2 Company Profile: 146
15.2.3 Financial Overview (USD Billion): 147
15.2.4 Product Benchmarking 147
- Recent Developments and Initiatives 147
15.2.5 SWOT Analysis 147
15.3 Merck & Co., Inc 149
15.3.1 Company Basic information 149
15.3.2 Company Profile: 149
15.3.3 Financial Overview (USD Billion): 150
15.3.4 Product Benchmarking 150
15.3.5 Recent Developments 150
15.3.6 SWOT Analysis 150
15.4 Baxter Healthcare Corporation 152
15.4.1 Company Basic information 152
15.4.2 Company Profile: 152
15.4.3 Financial Overview (USD Billion): 153
15.4.4 Product Benchmarking 153
15.4.5 Recent Developments 153
15.4.6 SWOT Analysis 153
15.5 Novartis AG 155
15.5.1 Company Basic information 155
15.5.2 Company Profile 155
15.5.3 Financial Overview (USD Billion): 156
15.5.4 Product Benchmarking 156
15.5.5 Recent Developments 156
15.5.6 SWOT Analysis 156
15.6 Abbott Laboratories 158
15.6.1 Company Basic information 158
15.6.2 Company Profile 158
15.6.3 Financial Overview (USD Billion): 159
15.6.4 Product Benchmarking 159
15.6.5 Recent Developments 159
15.6.6 SWOT Analysis 159
15.7 Sanofi S.A. 161
15.7.1 Company Basic information 161
15.7.2 Company Profile 161
15.7.3 Financial Overview (USD Billion): 162
15.7.4 Product Benchmarking 162
15.7.5 Recent Developments 162
15.7.6 SWOT Analysis 163
Chapter 16 Marketing Strategy Analysis, Distributors/Traders 164
16.1 Marketing Channel 164
16.1.1 Direct Marketing 164
16.1.2 Indirect Marketing 164
16.2 Market Positioning 165
16.2.1 Pricing Strategy 165
16.2.2 Brand Strategy 165
16.2.3 Target Client 166
Chapter 17 Future Outlook: Research Conclusion 167
17.1 Global Antibiotic Resistance Market Outlook, 2021 & 2028: Future Outlook 167
17.2 Conclusion 168
List of Tables
TABLE 1 Global Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 40
TABLE 2 Global Antibiotic Resistance Market Revenue, By Β-Lactam Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million) 42
TABLE 3 Global Antibiotic Resistance Market Revenue, By Cephalosporin, By Drug Class, By Region, 2015 - 2028 (USD Million) 44
TABLE 4 Global Antibiotic Resistance Market Revenue, By Quinolones Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million) 46
TABLE 5 Global Antibiotic Resistance Market Revenue, By Macrolide Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million) 48
TABLE 6 Global Antibiotic Resistance Market Revenue, By German, By Drug Class, By Region, 2015 - 2028 (USD Million) 50
TABLE 7 Global Antibiotic Resistance Market Revenue, By Other, By Drug Class, By Region, 2015 - 2028 (USD Million) 52
TABLE 8 Global Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 54
TABLE 9 Global Antibiotic Resistance Market Revenue, By CABP, By Disease, By Region, 2015 - 2028 (USD Million) 56
TABLE 10 Global Antibiotic Resistance Market Revenue, By cUTI, By Disease, By Region, 2015 - 2028 (USD Million) 58
TABLE 11 Global Antibiotic Resistance Market Revenue, By cIAI, By Drug Class, By Region, 2015 - 2028 (USD Million) 60
TABLE 12 Global Antibiotic Resistance Market Revenue, By BSI, By Drug Class, By Region, 2015 - 2028 (USD Million) 62
TABLE 13 Global Antibiotic Resistance Market Revenue, By Others, By Drug Class, By Region, 2015 - 2028 (USD Million) 64
TABLE 14 Global Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 66
TABLE 15 Global Antibiotic Resistance Market Revenue, By Hospital Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million) 68
TABLE 16 Global Antibiotic Resistance Market Revenue, By Retail Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million) 70
TABLE 17 Global Antibiotic Resistance Market Revenue, By Online Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million) 72
TABLE 18 Global Antibiotic Resistance Market Revenue, By Geographic Regions, 2015 - 2028 (USD Million) 74
TABLE 19 North America Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 76
TABLE 20 North America Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 77
TABLE 21 North America Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 78
TABLE 22 North America Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 80
TABLE 23 U.S. Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 81
TABLE 24 U.S. Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 82
TABLE 25 U.S. Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 82
TABLE 26 Canada Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 83
TABLE 27 Canada Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 84
TABLE 28 Canada Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 84
TABLE 29 Mexico Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 85
TABLE 30 Mexico Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 86
TABLE 31 Mexico Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 86
TABLE 32 Europe Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 88
TABLE 33 Europe Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 89
TABLE 34 Europe Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 89
TABLE 35 Europe Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 91
TABLE 36 Germany Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 92
TABLE 37 Germany Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 93
TABLE 38 Germany Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 93
TABLE 39 UK Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 94
TABLE 40 UK Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 95
TABLE 41 UK Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 95
TABLE 42 France Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 96
TABLE 43 France Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 97
TABLE 44 France Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 97
TABLE 45 Italy Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 98
TABLE 46 Italy Antibiotic Resistance Market Revenue, By Dis
The Leading Key Players in Antibiotic Resistance Market 1
